Ester Vanni

10.7k citations

34 papers · 7.9k indexed · 6 hit papers · h-index 25

Impact in

Hepatology top 0.2%
- Liver Disease and Transplantation
- Hepatitis C virus research
Endocrinology, Diabetes and Metabolism top 0.2%
- Diet, Metabolism, and Disease

Papers in ⓘ

Hepatology 16
- Hepatitis C virus research 7
- Liver Disease and Transplantation 7
- Liver Diseases and Immunity 4
Epidemiology 31
- Liver Disease Diagnosis and Treatment 30
- Hepatitis B Virus Studies 3

Co-authors: Elisabetta Bugianesi (31 shared papers)Giulio Marchesini (17 shared papers)Nicola Villanova (4 shared papers)Rita Manini (5 shared papers)Stefania Natale (4 shared papers)Mario Rizzetto (7 shared papers)Mario Rizzetto (5 shared papers)Nazario Melchionda (3 shared papers)
Journals: Hepatology (9 papers)Digestive and Liver Disease (3 papers)Journal of Clinical Medicine (2 papers)The American Journal of Gastroenterology (2 papers)Gastroenterology (2 papers)
Partner nations: Italy Australia United States

In The Last Decade

Ester Vanni

34 papers receiving 7.7k citations

Hit Papers

6 papers align trajectories log scale

Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease† 2010 · 497 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Hepatology
2008 Hepatology
2005 Hepatology
2005 The American Journal of Gastroenterology
2003 Hepatology
2002 Gastroenterology

Peers

Countries citing papers authored by Ester Vanni

Since Specialization

Citations

This map shows the geographic impact of Ester Vanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Vanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Vanni more than expected).

Fields of papers citing papers by Ester Vanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Vanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Vanni. The network helps show where Ester Vanni may publish in the future.

Co-authors

The 25 scholars most cited alongside Ester Vanni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ester Vanni Line = papers co-authored together Ester Vanni links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome Hepatology ·Giulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, Fernanda Cerrelli, Marco Lenzi, Rita Manini, Stefania Natale, Ester Vanni, Nicola Villanova, Nazario Melchionda, Mario Rizzetto Hit paper breakdown →	2003	2144
2	Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology ·Elisabetta Bugianesi, Nicola Leone, Ester Vanni, Giulio Marchesini, F. Brunello, P. Carucci, Alessandro Musso, Paolo De Paolis, Lorenzo Capussotti, Mauro Salizzoni, Mario Rizzetto Hit paper breakdown →	2002	1142
3	A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease The American Journal of Gastroenterology ·Elisabetta Bugianesi, E. Gentilcore, Rita Manini, Stefania Natale, Ester Vanni, Nicola Villanova, Ezio David, Mario Rizzetto, Giulio Marchesini Hit paper breakdown →	2005	544
4	Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes Hepatology ·Anna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi, M. Andreoletti, Agostino Colli, Ester Vanni, C. Bertelli, E. Fatta, Daniela Bignamini, Giulio Marchesini, Silvia Fargion Hit paper breakdown →	2008	530
5	Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease† Hepatology ·Nicola Villanova, Simona Moscatiello, Stefano Ramilli, Elisabetta Bugianesi, Donatella Magalotti, Ester Vanni, Marco Zoli, Giulio Marchesini Hit paper breakdown →	2005	507
6	Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease† Hepatology ·Luca Valenti, Ahmad Al‐Serri, Ann K. Daly, E. Galmozzi, Raffaela Rametta, Paola Dongiovanni, Valério Nobili, Enrico Mozzi, Giancarlo Roviaro, Ester Vanni, Elisabetta Bugianesi, Marco Maggioni, Anna Ludovica Fracanzani, Silvia Fargion, Christopher P. Day Hit paper breakdown →	2010	497
7	From the metabolic syndrome to NAFLD or vice versa? Digestive and Liver Disease ·Ester Vanni, Elisabetta Bugianesi, Anna Kotronen, Samuele De Minicis, Hannele Yki‐Järvinen, Gianluca Svegliati‐Baroni	2010	408
8	Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver Hepatology ·Elisabetta Bugianesi, Paola Manzini, Sergio D’Antico, Ester Vanni, Filomena Longo, Nicola Leone, P. Massarenti, Antonio Piga, Giulio Marchesini, Mario Rizzetto	2004	345
9	Plasma Adiponectin in Nonalcoholic Fatty Liver Is Related to Hepatic Insulin Resistance and Hepatic Fat Content, Not to Liver Disease Severity The Journal of Clinical Endocrinology & Metabolism ·Elisabetta Bugianesi, Uberto Pagotto, Rita Manini, Ester Vanni, Amalia Gastaldelli, Rosaria De Iasio, E. Gentilcore, Stefania Natale, Maurizio Cassader, Mario Rizzetto, Renato Pasquali, Giulio Marchesini	2005	335
10	Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study The American Journal of Gastroenterology ·Luca Valenti, Anna Ludovica Fracanzani, Paola Dongiovanni, Elisabetta Bugianesi, Giulio Marchesini, Paola Manzini, Ester Vanni, Silvia Fargion	2007	220
11	HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Gastroenterology ·Luca Valenti, Anna Ludovica Fracanzani, Elisabetta Bugianesi, Paola Dongiovanni, E. Galmozzi, Ester Vanni, Elena Canavesi, Ezio Lattuada, Giancarlo Roviaro, Giulio Marchesini, Silvia Fargion	2009	220
12	Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis Hepatology ·Elisabetta Bugianesi, Giulio Marchesini, E. Gentilcore, Ian Homer Y., Ester Vanni, Mario Rizzetto, Jacob George	2006	129
13	Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C # Hepatology ·Ester Vanni, Maria Lorena Abate, E. Gentilcore, Ingrid J. Hickman, Roberto Gambino, Maurizio Cassader, Antonina Smedile, Ele Ferrannini, Mario Rizzetto, Giulio Marchesini, Amalia Gastaldelli, Elisabetta Bugianesi	2009	127
14	The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease Liver International ·Salvatore Petta, Ester Vanni, Elisabetta Bugianesi, V. Di Marco, Calogero Cammà, Daniela Cabibi, L. Mezzabotta, Antonio Craxı̀	2014	102
15	Intrauterine Growth Retardation, Insulin Resistance, and Nonalcoholic Fatty Liver Disease in Children Diabetes Care ·Valério Nobili, Matilde Marcellini, Giulio Marchesini, Ester Vanni, Melania Manco, Alberto Villani, Elisabetta Bugianesi	2007	101
16	Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity Journal of Hepatology ·Anna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi, Ester Vanni, Antonio Grieco, Luca Miele, Dario Consonni, E. Fatta, Rosa Lombardi, Giulio Marchesini, Silvia Fargion	2010	95
17	Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander Seminars in Liver Disease ·Ester Vanni, Andrea Marengo, L. Mezzabotta, Elisabetta Bugianesi	2015	64
18	Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease Hepatology ·Chiara Rosso, L. Mezzabotta, Melania Gaggini, Federico Salomone, Roberto Gambino, Andrea Marengo, Francesca Saba, Ester Vanni, Ramy Younes, Chiara Saponaro, E. Buzzigoli, Gian Paolo Caviglia, Maria Lorena Abate, Antonina Smedile, Mario Rizzetto, Maurizio Cassader, Amalia Gastaldelli, Elisabetta Bugianesi	2015	57
19	Obesity and Liver Cancer Clinics in Liver Disease ·Ester Vanni, Elisabetta Bugianesi	2013	53
20	NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes Current Diabetes Reports ·Elisabetta Bugianesi, Ester Vanni, Giulio Marchesini	2007	51

About Ester Vanni

Ester Vanni is a scholar working on Hepatology, Epidemiology, Endocrinology, Diabetes and Metabolism, Gastroenterology and Hematology, having authored 34 papers that have together received 7.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (30 papers), Diet, Metabolism, and Disease (8 papers), Hepatitis C virus research (7 papers), Liver Disease and Transplantation (7 papers), Pancreatitis Pathology and Treatment (5 papers), Liver Diseases and Immunity (4 papers), Hepatitis B Virus Studies (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Hepatology (2.4k citations), Endocrinology, Diabetes and Metabolism (3.5k citations), Epidemiology (7.0k citations), Pathology and Forensic Medicine (1.2k citations) and Cardiology and Cardiovascular Medicine (1.1k citations). Ester Vanni has collaborated with scholars based in Italy, Australia and United States. Frequent co-authors include Elisabetta Bugianesi, Giulio Marchesini, Nicola Villanova, Rita Manini, Stefania Natale, Mario Rizzetto, Mario Rizzetto, Nazario Melchionda, Gabriele Forlani and Marco Lenzi. Their work appears in journals such as Hepatology, Digestive and Liver Disease, Journal of Clinical Medicine, The American Journal of Gastroenterology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact